News > Coronavirus vaccine: As lab execs sell shares worth millions, questions arise

Coronavirus vaccine: As lab execs sell shares worth millions, questions arise

Moneycontrol | 15/11/2020 03:59 PM | Click to read full article

On the very day that pharmaceutical giant Pfizer announced preliminary data showing its vaccine was 90 per cent effective against the coronavirus, its chief executive Albert Bourla sold shares worth $5.6 million.

When a top executive needs to sell shares to pay for a yacht, a new house or his children's education, the public rarely is aware of it. But with the pandemic raging, the laboratories are under intense scrutiny.

-